17
Views
65
CrossRef citations to date
0
Altmetric
Original Article

Antiproliferative Activity of Mammalian Lignan Derivatives Against the Human Breast Carcinoma Cell Line, ZR-75-1

, , , , , & show all
Pages 595-602 | Published online: 11 Jun 2009

References

  • Stitch S. R., Toumba J. K., Groen M. B., et al. Excretion, isolation and structure of a new phenolic constituent of female urine. Nature 1980; 287: 738–740
  • Setchell K. DR, Lawson A. M., Mitchell F. L., et al. Lignans in man and animal species. Nature 1980; 287: 740–742
  • Setchell K. DR, Axelson M. The excretion of lignans in rats-evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett 1981; 123: 337–342
  • Setchell K. DR, Lawson A. M., Conway E., et al. The identification of the lignans trans-2,3-bis(3-hydmxybenzyl)-γ-butyrolactone and 2,3-bis(3-hydroxybenzyl)-butane-l,4-diol in human and animal urine. Biochem J 1981; 197: 447–458
  • Setchell K. DR, Lawson A. M., Borriello S. P., et al. Lignan fonnation in man-micmbial involvement and possible roles in relation to cancer. Lancet 1981; 1: 4–7
  • Adlercreutz H., Fotsis T., Heikkinen R., et al. Diet and urinary excretion of lignans in female subjects. Med Biol 1981; 59: 259–261
  • Adlercreuk H., Fotsis T., Heikkinen R., et al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 1982; 2: 1295–1299
  • Hartwell J. L. Types of anticancer agents isolated from plants. Cancer Treat Rep 1976; 60: 1031–1067
  • Barclay A. S., Perdue R. E., Jr. Distribution of anticancer activity in higher plants. Cancer Treat Rep 1976; 60: 1081–1113
  • Belletire J. L., Fremont S. L. The total synthesis of enterolactone. Tetrahedron Lett 1986; 27: 127–130
  • Engel E. W., Young N. A., Tralka T. S., et al. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res 1978; 38: 3352–3364
  • Robbins A. R., Baker R. M. (Na, K)ATPase activity in membrane preparations of ouabain-resistant Hela cells. Biochemistry 1977; 16: 5163–5168
  • Lowry O. H., Rosebrough N. J., Farr A. L., et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
  • Nakao T., Tashima Y., Nagao K., et al. Highly specific sodium-potassium-activated adenosine triphosphatase from various tissues of rabbit. Biochem Biophys Res Comm 1965; 19: 755–758
  • Stihein H. Activity of a new glycosidic lignan derivatives (W-16–213) related to podophyllotoxin in experimental tumours. Eur J Cancer 1973; 9: 215–221
  • Joland S. D., Wiedhope R. M., Cole J. R. Cytotoxic agents from Bursera morelensis (Bursemxae): Deoxypodophyllotoxin and a new lignan, 5′desmethoxypodophyllotoxin. J Pharmac Sci 1977; 66: 892–893
  • Weiss S. G., Tin-Wa M., Perdue R. E., Jr, et al. Potential anticancer agents 11: antitumor and cytotoxic lignans from linum album (Linaceae). J Pharmac Sci 1975; 64: 95–98
  • Savel H. Clinical experience with intravenous podophyllotoxin. Proc Am Assoc Cancer Res 1964; 556
  • Bleyer W. A., Krivit W., Chard R. L., Jr, et al. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group. Cancer Treat Rep 1979; 63: 977–981
  • Gupta R. S. Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16–213. Cancer Res 1983; 43: 1568–1574
  • Fagoo M., Braquet P., Robin J. P., et al. Evidence that mammalian lignans show endogenous digitalis-like activities. Biochem Biophys Res Comm 1986; 134: 1064–1070
  • Braquet P., Senn N., Robin J. P., et al. Inhibition of the erythrocyte Na+, K+-pump by mammalian lignans. Pharmacol Res Comm 1986; 18: 227–239
  • Emmelot P., Bos C. I. Studies on plasma membranes. VI. Differences in the effect of temperature on the ATPase and (Na+-K+)-ATPase activities of plasma membranes isolated from rat liver and hepatoma. Biochim Biophys Acta 1968; 150: 354–363
  • Milo G. E., Yohn D. S. Alterations of enzymes associated with plasma membranes and cellular organelles during infection of CV-1 cells with Yaba tumor poxvirus. Cancer Res 1975; 35: 199–206
  • Wilson P. D. Enzyme patterns in non-neoplastic and spontaneously transformed tissue culture cells: A histochemical and biochemical study. J Pathol 1974; 114: 21–27
  • Kasarov L. B., Friedman H. Enhanced Na+-K+-activated adenosine triphosphatase activity in transformed fibroblasts. Cancer Res 1974; 34: 1862–1865
  • Elligsen J. D., Thompson J. E., Frey H. E., et al. Correlation of (Na+-K+)-ATPase activity with growth of normal and transformed cells. Exp Cell Res 1974; 87: 233–240
  • Gupta R. S., Chopra A. Cross-resistance and biochemical studies with two classes of Hela cell mutant resistant to cardiac glycosides. J Biol Chem 1985; 260: 6843–6850
  • Chopra A., Gupta R. S. Biochemical ad cross-resistance studies with Hela cell mutants resistant to cardiac glycoside SC4453. J Biol Chem 1986; 261: 2034–2040
  • Benade L. E., Talbot N., Tagliafem P., et al. Ouabain sensitivity is linked to m-transformation in human HOS cells. Biochem Biophsy Res Comm 1986; 136: 807–814

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.